In March 2024, one of the biosecurity laws restricting transactions with Chinese bio companies happened to pass the U.S. Congress, and now the global contract development and production- CDMO companies happen to be trying to secure production facilities within the U.S. This is because of the concerns that bio could as well be the next […]

The post US Enacts Biosecurity Law Blocking Chinese Bio Company Deals first appeared on World Pharma Today.